Prescription Only Generic
Skip to product information
1 of 0

Lenvat

Lenvat

Active ingredient : Lenvatinib Lenvatinib

27 people are viewing this right now
Regular price $108.75
Regular price Sale price $108.75
Sold out
USD $108.75 for 30 Capsules
Lenvat (Lenvatinib) is a targeted cancer therapy that inhibits tumor growth by blocking specific pathways involved in cancer cell proliferation and angiogenesis. It is commonly used to treat various types of cancer, including thyroid cancer and hepatocellular carcinoma. Lenvat offers patients a powerful option for managing their condition, aiming to improve outcomes and enhance quality of life. Discover how Lenvat can be a vital part of your cancer treatment plan.

Dosage
SKU: Lenvat

Active ingredient

Lenvatinib

Shipping & Returns

Free shipping and returns available on all orders!

We ship all US domestic orders within 5-10 business days

View full product details

Product Overview

Lenvat (Lenvatinib) is an innovative medication used primarily for the treatment of certain types of cancer. It is designed to inhibit tumor growth by targeting specific pathways involved in cancer progression.

Indications

Lenvat is commonly prescribed for patients with:

  • Thyroid cancer
  • Hepatocellular carcinoma
  • Renal cell carcinoma

How It Works

Lenvatinib functions as a receptor tyrosine kinase inhibitor. By blocking the signals that promote tumor growth and angiogenesis, it helps slow down the progression of cancer.

Dosage and Administration

The recommended dosage of Lenvat varies based on the condition being treated. It is crucial to follow the healthcare provider's instructions for optimal results.

Possible Side Effects

Common side effects may include:

  • Fatigue
  • Hypertension
  • Nausea
  • Diarrhea

Patients should report any severe side effects to their healthcare provider immediately.

Precautions

Before starting Lenvat, inform your doctor about any pre-existing conditions or allergies. Regular monitoring may be required during treatment.

Conclusion

Lenvat (Lenvatinib) represents a significant advancement in cancer therapy. With its targeted approach, it offers hope for patients battling various forms of cancer.